Synopsys Stock: The Price Tag Hides a Patient Investor’s Discount - Trefis

Synopsys (SNPS), a leading semiconductor design software provider, is at the heart of the AI-driven chip design boom. While its current stock price trades at a lofty 92.5 times trailing earnings, a fo... Read original →

As a leader in semiconductor design software, Synopsys is at the heart of the AI-driven chip design boom. While its current stock price may seem high, forward-looking valuations actually present a discount for patient investors. Technologically, the surge in AI-driven chip demand will drive the industry towards more efficient design processes, with Synopsys's tech stack playing a pivotal role. However, US export restrictions on technology to Taiwan, China and Hong Kong, China, could increase operational costs and impact supply chain security. Competitors like Cadence might respond by ramping up R&D, intensifying market competition. Over the next 12-24 months, Synopsys is expected to benefit from sustained AI demand, but geopolitical risks must be monitored. Long-term, investors holding Synopsys stock are likely to see gains as the market revalues the company based on realized earnings.